Scientists at North Carolina State University and the University of North Carolina at Chapel Hill have developed a new way of delivering a clot buster and a mitigating drug to limit damage due to reperfusion.
Currently, serious blockages leading to the myocardium are typically broken up in the cath lab, usually with a stent left behind to support (Read more...)